# Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/post-hoc-analysis-of-randomised-placebo-controlled-double-blind-study-mci186-19/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Koji Takei,Fumihiro Takahashi,X. Shawn Liu,Kikumi Tsuda,Joseph Palumbo |
| Citations | 32 |
| DOI | 10.1080/21678421.2017.1361443 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/21678421.2017.1361443?needAccess=true |
| OpenAlex ID | https://openalex.org/W2751841726 |
| PMID | 28872913 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Fumihiro Takahashi](https://scholariq.org/researchers/fumihiro-takahashi/)

## Paper journal

- [Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration](https://scholariq.org/journals/amyotrophic-lateral-sclerosis-and-frontotemporal-degeneration/)

## Paper primary topic

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)

## Paper topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.